1400792-98-4

Basic information

• Product Name: C₂₄H₃₇N₃O₇
• Synonyms: C₂₄H₃₇N₃O₇
• CAS NO: 1400792-98-4
• Molecular Weight: 479.574
• Mol File: 1400792-98-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₄H₃₇N₃O₇(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₄H₃₇N₃O₇(1400792-98-4)
• EPA Substance Registry System: C₂₄H₃₇N₃O₇(1400792-98-4)

Safety Data

• Hazardous Substances Data: 1400792-98-4(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 175463-32-8 3-cyano-4-oxopyrrolidine-1-carboxylic acid tert-butyl ester 
• 175463-35-1 tert-butyl 3-(tert-butoxycarbonyl)aminomethyl-4-oxopyrrolidine-1-carboxylate 
• 7314-44-5 2,4-dimethoxylbenzyl alcohol 
• 175463-36-2 tert-butyl 3-(tert-butoxycarbonyl)aminomethyl-4-(hydroxyimino)pyrrolidine-1-carboxylate 
• 161919-74-0 1-bromomethyl-2,4-dimethoxybenzene 

Downstream Products

• 1356199-60-4 7-[3-(benzylideneamino)methyl-4-(2',4'-dimethxoybenzyl-oxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid 

Relevant articles and documents

Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety

A series of novel gemifloxacin (GMFX) derivatives containing a substituted benzyloxime moiety with remarkable improvement in lipophilicity were synthesized. The target compounds evaluated for their in vitro antibacterial activity against representative strains. Our results reveal that most of the target compounds have considerable potency against all of the tested Gram-positive strains including MRSA and MRSE (MIC: 90: 1 μg/mL) is 8-fold more active than GMFX, and 2-fold more active than GMFX and moxifloxacin against MRSE clinical isolates (MIC90: 4 μg/mL). Crown Copyright